GlassBury AI combines agentic patient matching with culturally sensitive community education to eliminate healthcare disparities. By pairing AI with expert-curated workshops, we build the trust necessary to connect underrepresented patients with life-changing clinical trials.

Advances in Neurological Disease Detection: A New Era of Precision and Early Intervention

Neurological diseases, encompassing a vast spectrum of disorders affecting the brain, spinal cord, and peripheral nerves, pose a significant and growing global health challenge. Conditions such as Alzheimer's disease, Parkinson's disease, multiple sclerosis, and stroke not only inflict immense personal suffering but also place a substantial burden on healthcare systems

Read More
DNA, AI in Healthcare, Clinical Trials, FDA Corey Hubbafd DNA, AI in Healthcare, Clinical Trials, FDA Corey Hubbafd

The Sociogenomics Revolution

For generations, humanity has grappled with one of life's most profound questions: are we products of our genes or our upbringing? This "nature versus nurture" debate has fueled countless discussions, academic papers, and even political stances. On one side stand the "blank-slaters," who believe our environment is the primary sculptor of who we become. On the other, the "hereditarians" argue that our destiny is largely etched in our genetic code.

Read More

Why We Can't Sleep in Early Alzheimer's: The New Science of Brain Inflammation

For years, we have known that people with early-stage Alzheimer’s often struggle to get a good night's rest. For a long time, scientists thought this was simply because of "plaques"—sticky protein buildups called amyloid—clogging up the brain.

Read More

Lecanemab Real-World Safety: Duke Health Study Insights for Alzheimer’s Patients

For decades, the search for a way to slow down Alzheimer’s disease felt like chasing a horizon that never got closer. However, the arrival of anti-amyloid therapies like lecanemab has shifted the conversation from "what if" to "how." While clinical trials provide a controlled environment to test these drugs

Read More

The Role of AI in Therapeutic Drug Research and Development: Benefits and Challenges

Artificial intelligence (AI) has emerged as a transformative technology across various sectors, and its potential impact on therapeutic drug research and development is significant. By leveraging AI algorithms and machine learning, researchers can potentially accelerate the drug discovery process, identify promising drug candidates, and optimize treatment strategies. However, the integration of AI

Read More